Core Viewpoint - Perfect Medical (01830.HK) reported a 21.7% decrease in revenue to HKD 486 million for the six months ending September 30, 2025, with a profit attributable to equity holders of HKD 94.8 million, reflecting a 32.7% decline year-on-year, although a 43.4% increase compared to the previous six-month period [1] Financial Performance - Revenue decreased by 21.7% to HKD 486 million [1] - Profit attributable to equity holders was HKD 94.8 million, down 32.7% year-on-year but up 43.4% from the previous six-month period [1] - Basic earnings per share were HKD 0.075 [1] - Proposed interim dividend is HKD 0.076 per share, with a payout ratio of 101.3% [1] - The company has maintained a payout ratio of 100% or above for eleven consecutive years [1] Market Environment - The core Hong Kong market continues to face structural challenges impacting discretionary spending in service categories [1] - Although overall retail sales have shown slight recovery since May 2025 due to inbound tourism, the recovery is primarily in retail goods rather than medical beauty services [1] - The increase in outbound travel and overseas spending by local residents has significantly affected the company's performance by draining discretionary income from the local service market [1] - A cooling labor market and changing consumer habits have led to a more cautious overall consumption sentiment, resulting in a noticeable decline in consumer willingness to spend on medical beauty and beauty services [1] - Multiple factors have temporarily limited revenue growth and significantly impacted the company's mid-term financial performance [1]
完美医疗(01830.HK)中期收益减少21.7%至4.86亿港元